Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Gastroenterology
    • Terlipressin more...

    Terlipressin more effective than noradrenaline in patients with hepatorenal syndrome

    Written by Medha Baranwal Baranwal Published On 2018-09-05T19:10:24+05:30  |  Updated On 5 Sept 2018 7:10 PM IST
    Terlipressin more effective than noradrenaline in patients with hepatorenal syndrome

    Infusion of terlipressin in acute-on-chronic liver failure (ACLF) patients with hepatorenal syndrome-acute kidney injury (HRS-AKI) resulted in improved survival and earlier and higher response than noradrenaline, according to a study published in the journal Hepatology.


    HRS carries a high short‐term mortality in patients with cirrhosis and ACLF. Terlipressin and noradrenaline are routinely used and found to be equally effective in cirrhosis with HRS. Vinod Arora, Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India, and colleagues conducted the study to compare the efficacy of terlipressin with noradrenaline in ACLF patients with HRS.


    The treatment of hepatorenal syndrome has been focused on patients with decompensated cirrhosis. However, HRS related to acute-on-chronic liver failure is quite common in clinical practice, and little is known regarding the efficacy of vasoconstrictor therapy in this population.


    In this open-label randomized controlled trial, ACLF patients with HRS-AKI were randomized to albumin with the infusion of noradrenaline (0.5‐3 mg/hr) (n=60) or terlipressin (2‐12 mg/d) (n=60). The course of AKI, response to treatment and outcome were then studied.


    Also Read: Antibiotic Combination Increases Acute Kidney Injury Risk In Hospitalised Children


    Key Findings:

    • Baseline characteristics including AKI stage and sepsis‐related HRS‐AKI were comparable between the groups.

    • Compared to noradrenaline, terlipressin achieved greater day4 (26.1% vs.11.7%) and day 7 (41.7% vs. 20%) response.

    • Reversal of HRS was also better with terlipressin (40% vs.16.7%)with a significant reduction in the requirement of renal replacement therapy(56.6% vs. 80%,p=0.006)and improved 28‐day survival (48.3% vs. 20%).

    • Adverse events limiting the use of drugs were higher with terlipressin than noradrenaline [23.3% versus 8.3%] but were reversible.

    • On multivariate analysis, high MELD (OR 1.10, CI=1.009‐1.20,p=0.03) and noradrenaline compared to terlipressin (OR 3.05,CI=1.27‐7.33,p=0.01)predicted non‐response to therapy.

    • Use of noradrenaline compared to terlipressin was also predictive of higher mortality (HR 2.08, CI=1.323.30,p=0.002).




    "Acute kidney injury in ACLF carries a high mortality. Infusion of terlipressin gives earlier and higher response than noradrenaline with improved survival in ACLF patients with HRS‐AKI," concluded the authors.


    For further reference log on to https://doi.org/10.1002/hep.30208

    chronicCirrhosisdiseaseHepatology journalhepatorenal syndromeHRS AKIkidneykidney injuryliverliver failuremortalitynoradrenalineresponsesurvivalterlipressinVasoconstrictorVinod Arora
    Source : With inputs from Hepatology

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok